Viking Therapeutics VKTX
NASDAQ VKTX
$26.38 -0.33 (-1.24%)
At close: Oct 21, 2026 · 4:00 PM EDT

Viking Therapeutics (VKTX) Other Non-Current Liabilities (2015 - 2018)

Updated

Viking Therapeutics (VKTX) posted Other Non-Current Liabilities of $12,000 for Q4 2018.

Analysis

Viking Therapeutics (VKTX) Other Non-Current Liabilities (2015 - 2018) Analysis & Trends

Since Q3 2015, Viking Therapeutics has reported Other Non-Current Liabilities for 9 quarters.

  • Annual Other Non-Current Liabilities shows a three-year compound annual growth rate of -27.3% (FY2015 to FY2018).
  • In prior years, Viking Therapeutics' Other Non-Current Liabilities was $16,307 in FY2016 (-47.8%) and $31,239 in FY2015.
  • The Q4 2018 figure stands as the highest quarterly Other Non-Current Liabilities since Q4 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Viking Therapeutics 3.07 Bn 545.20 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 12,000.00
Jun 30, 2017 6,054.00
Mar 31, 2017 10,862.00
Dec 31, 2016 16,307.00
Sep 30, 2016 20,476.00
Jun 30, 2016 24,646.00
Mar 31, 2016 27,624.00
Dec 31, 2015 31,239.00
Sep 30, 2015 19,149.00
API Access

Viking Therapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=VKTX&period=max&api_key=YOUR_API_KEY